Suppr超能文献

原发性主动脉十二指肠瘘的血管内治疗:一例病例报告的2年随访

Endovascular treatment of a primary aortoduodenal fistula: 2-year follow-up of a case report.

作者信息

Papacharalambous Gerasimos, Skourtis Georgios, Saliveros Apostolos, Karagannidis Dimitrios, Makris Sotirios, Panousis Panagiotis, Ktenidis Kiriakos

机构信息

Department of Vascular Surgery, KAT Hospital, Athens, Greece.

出版信息

Vasc Endovascular Surg. 2007 Jun-Jul;41(3):265-70. doi: 10.1177/1538574407300919.

Abstract

The purpose is to evaluate the role of endovascular management for primary aortoduodenal fistula in poor surgical risk patients. A 70-year-old-man was admitted at the emergency room of our hospital with recurrent upper-gastrointestinal bleeding. A diagnostic workup was suggestive of a primary aortoduodenal fistula caused by erosion of an infrarenal abdominal aortic aneurysm. Intractable cardiac arrhythmia, recurrent hemorrhage, and poor patient condition were compatible with an exceedingly high surgical risk. The fistula was successfully treated, and gastrointestinal bleeding was eliminated with placement of a Lifepath endoluminal aortoiliac stent graft. At the 21-month follow-up, the patient was not presenting with symptoms and signs of graft infection, and radiologic studies confirmed decreasing aneurysm size without associated signs of local sepsis. Endovascular stent grafts can efficiently arrest massive exsanguination in critically ill patients with primary aortoenteric fistula. The risk of graft infection remains the most serious problem associated with this approach.

摘要

目的是评估血管内治疗在手术风险高的原发性主动脉十二指肠瘘患者中的作用。一名70岁男性因反复上消化道出血入住我院急诊室。诊断性检查提示原发性主动脉十二指肠瘘由肾下腹主动脉瘤侵蚀所致。顽固性心律失常、反复出血及患者状况差提示手术风险极高。通过置入Lifepath腔内主动脉髂动脉支架移植物成功治疗了瘘管,消除了胃肠道出血。在21个月的随访中,患者未出现移植物感染的症状和体征,影像学检查证实动脉瘤大小减小,无局部感染迹象。血管内支架移植物可有效阻止原发性主动脉肠瘘危重症患者的大量失血。移植物感染风险仍然是该治疗方法最严重的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验